Rachel N. Andrews

Rachel N. Andrews

Auto-generated profile, based on publicly available information

Rachel N. Andrews

Department of Radiation Oncology, Section on Radiation Biology, Wake Forest University School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC, United States

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2018 in Alzheimer's & Dementia
Verified
Journal Article
Open access
CLCaitlin S. Latimer
Caitlin S. Latimer
CSCarol A. Shively
Carol A. Shively
CKC. Dirk Keene
C. Dirk Keene
MJMatthew Jorgensen
Matthew Jorgensen
RARachel N. Andrews
Rachel N. Andrews
SCSuzanne Craft
Suzanne Craft
Introduction: Nonhuman primates may serve as excellent models of sporadic age‐associated brain β‐amyloid deposition and Alzheimer's disease pathologic changes. We examined whether a vervet nonhuman primate model recapitulated pathologic, physiologic, and behavioral features of early Alzheimer's disease.Methods: Nine middle‐aged (mean = 11.2 years) and nine aged (mean = 21.7 years) female vervet/African green monkeys underwent cerebrospinal fluid collection, gait speed measurement, and neuroimaging before neuropathologic assessment.Results: β‐amyloid plaques were identified in all aged vervets and paired helical filament tau immunoreactivity was observed in all animals. Cerebrospinal fluid β‐amyloid42 and gait speed correlated negatively with age and plaque density. Greater plaque and paired helical filament tau burden predicted reduced volumes and CMRg in several brain regions.Discussion: We observed a coordinated set of relationships among neuropathologic, cerebrospinal fluid, imaging, and behavioral modalities consistent with early Alzheimer's disease. Our results support future use of the vervet model to explore disease mechanisms, biomarkers, and novel therapeutic strategies.

8 April 2019 in Current Treatment Options in Oncology
Verified
Journal Article
Closed access
PDF file
CCChristina K. Cramer
Christina K. Cramer
TCTiffany L. Cummings
Tiffany L. Cummings
RARachel N. Andrews
Rachel N. Andrews
RSRoy Strowd
Roy Strowd
SRStephen R. Rapp
Stephen R. Rapp
GLGlenn J. Lesser
Glenn J. Lesser

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
DTDaniel J Tyrrell
Daniel J Tyrrell
MBManish S Bharadwaj
Manish S Bharadwaj
MJMatthew Jorgensen
Matthew Jorgensen
TRThomas C Register
Thomas C Register
CSCarol Shively
Carol Shively
AMAnthony J A Molina
Anthony J A Molina
Blood‐based bioenergetic profiling provides a minimally invasive assessment of mitochondrial health shown to be related to key features of aging. Previous studies show that blood cells recapitulate mitochondrial alterations in the central nervous system under pathological conditions, including the development of Alzheimer’s disease. In this study of nonhuman primates, we focus on mitochondrial function and bioenergetic capacity assessed by the respirometric profiling of monocytes, platelets, and frontal cortex mitochondria. Our data indicate that differences in the maximal respiratory capacity of brain mitochondria are reflected by CD14+ monocyte maximal respiratory capacity and platelet and monocyte bioenergetic health index. A subset of nonhuman primates also underwent [18F] fluorodeoxyglucose positron emission tomography (FDG‐PET) imaging to assess brain glucose metabolism. Our results indicate that platelet respiratory capacity positively correlates to measures of glucose metabolism in multiple brain regions. Altogether, the results of this study provide early evidence that blood‐based bioenergetic profiling is related to brain mitochondrial metabolism. While these measures cannot substitute for direct measures of brain metabolism, provided by measures such as FDG‐PET, they may have utility as a metabolic biomarker and screening tool to identify individuals exhibiting systemic bioenergetic decline who may therefore be at risk for the development of neurodegenerative diseases.

1 May 2017 in Radiation Research
Verified
Journal Article
Closed access
PDF file
RARachel N. Andrews
Rachel N. Andrews
LMLinda J. Metheny-Barlow
Linda J. Metheny-Barlow
APAnn M. Peiffer
Ann M. Peiffer
DHDavid B. Hanbury
David B. Hanbury
JTJanet A. Tooze
Janet A. Tooze
JCJ. Mark Cline
J. Mark Cline
Radiation Research publishes work dealing with radiation effects and related subjects in the areas of physics, chemistry, biology and medicine.

1 July 2010 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
MCMelissa A. Cimafranca
Melissa A. Cimafranca
JDJuanmahel Davila
Juanmahel Davila
GEGail C. Ekman
Gail C. Ekman
RARachel N. Andrews
Rachel N. Andrews
SNSteven L. Neese
Steven L. Neese
PCPaul S. Cooke
Paul S. Cooke
Soy-based infant formulas are widely used in the United States and some other countries. These formulas contain high levels of the estrogenic isoflavone geniste

22 July 2018 in Radiation Research
Verified
Journal Article
Closed access
RARachel N. Andrews
Rachel N. Andrews
DCDavid L. Caudell
David L. Caudell
LMLinda J. Metheny-Barlow
Linda J. Metheny-Barlow
APAnn M. Peiffer
Ann M. Peiffer
JTJanet A. Tooze
Janet A. Tooze
JCJ. Mark Cline
J. Mark Cline
Late-delayed radiation-induced brain injury (RIBI) is a major adverse effect of fractionated whole-brain irradiation (fWBI). Characterized by progressive cognitive dysfunction, and associated cerebrovascular and white matter injury, RIBI deleteriously affects quality of life for cancer patients. Despite extensive morphological characterization of the injury, the pathogenesis is unclear, thus limiting the development of effective therapeutics. We previously reported that RIBI is associated with increased gene expression of the extracellular matrix (ECM) protein fibronectin (FN1). We hypothesized that fibronectin contributes to perivascular ECM, which may impair diffusion to the dependent parenchyma, thus contributing to the observed cognitive decline. The goal of this study was to determine the localization of fibronectin in RIBI and further characterize the composition of perivascular ECM, as well as identify the cell of origin for FN1 by in situ hybridization. Briefly, fibronectin localized to the vascul...